Cash-pay clinics are putting peptide menus on the same pages as memberships and telehealth booking. Operators and counsel still have to decide whether that copy is a medical-practice claim, a drug advertisement, or both.
Cash-pay clinics are putting peptide menus on the same pages as memberships and telehealth booking.
A staff note on launch transparency: where AI may assist drafting, where humans stay accountable, and what we will not publish.
Branded GLP-1 injections are easier to obtain than they were during the shortage. Direct-to-consumer telehealth sites that built weight-loss programs on compounded versions are changing menus, prices, and pharmacy-partner lists in public.
FDA's post-shortage compounding reminders and "essentially a copy" framing are reshaping playbooks for 503A pharmacies, 503B facilities, and virtual prescribing programs.
Every letter, rule and deadline, from the source. Structured records you can cite, filter and download.
Records appear here as soon as they are verified.
Reference databases
FDA warning and untitled letters to telehealth companies, compounders and peptide sellers, with responses and close-outs.
CSV · 27 columns · Updated when FDA posts new letters; we check FDA’s postings at least weekly.
Approvals, rules, guidance, recalls and enforcement from FDA, DEA, CMS, HHS and FTC.
CSV · 27 columns · Updated as agencies publish; Federal Register and FDA postings are checked each business day.
Countdowns to expiring telehealth flexibilities, with legal authority and timelines.
CSV · 16 columns · Checked at least weekly, and on the day any extension or rule is published.
503A status, FDA approval, PCAC votes and WADA status for peptides sold online.
12 Peptides with a 503A status
CSV · 19 columns · Checked at least weekly and whenever FDA updates its 503A lists or holds a PCAC meeting.